Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha, Cengiz Inal, Taofeek K. Owonikoko
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 219

Showing 1-25 of 219 citing articles:

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 213
Emerging phagocytosis checkpoints in cancer immunotherapy
Yue Liu, Yanjin Wang, Yanrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell
Gerda Kildisiute, Waleed M. Kholosy, Matthew D. Young, et al.
Science Advances (2021) Vol. 7, Iss. 6
Open Access | Times Cited: 126
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
Luke Maggs, Giulia Cattaneo, Ali Emre Dal, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 114
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 102
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 77
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
Ya-Jui Lin, Leila A. Mashouf, Michael Lim
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Aberrant Sialylation in Cancer: Therapeutic Opportunities
Jennifer Munkley
Cancers (2022) Vol. 14, Iss. 17, pp. 4248-4248
Open Access | Times Cited: 70
CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression
Andrew S. Luksik, Eli Yazigi, Pavan P. Shah, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1414-1414
Open Access | Times Cited: 49
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
Salma Khan, Yeonjoo Choi, Mysore S. Veena, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
Adam Nelson, Jordan D. Lukacs, Brent Johnston
Cancers (2021) Vol. 13, Iss. 20, pp. 5174-5174
Open Access | Times Cited: 86
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
Jiao Wang, Sandra Toregrosa-Allen, Bennett D. Elzey, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 61
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
Chiara Corti, Konstantinos Venetis, Elham Sajjadi, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 6, pp. 593-605
Open Access | Times Cited: 54
Origin and Therapies of Osteosarcoma
Brice Moukengué, Morgane Lallier, Louise Marchandet, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3503-3503
Open Access | Times Cited: 50
The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better
Rui Mao, Wanqing Kong, Yukai He
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1597-1597
Open Access | Times Cited: 31
Biology of GD2 ganglioside: implications for cancer immunotherapy
Pierre Machy, Erwan Mortier, Stéphane Birklé
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
Roselia Ciccone, Concetta Quintarelli, Antonio Camera, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2545-2557
Open Access | Times Cited: 14
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma
Daniel Fowler, Marta Barisa, Alba Southern, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 749
Open Access | Times Cited: 10
Targeting macrophages in cancer immunotherapy: Frontiers and challenges
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
Rishabh Sharma, Jaya Yadav, Sajad Ahmad Bhat, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy
Cristina Larrosa, Margarida Simão-Rafael, Noelia Salvador, et al.
Frontiers in Pediatrics (2025) Vol. 12
Open Access | Times Cited: 1
Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy
Giovanni Fucá, Andrea Spagnoletti, Margherita Ambrosini, et al.
ESMO Open (2021) Vol. 6, Iss. 1, pp. 100046-100046
Open Access | Times Cited: 48
Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy
Yanting Duan, Ruoqi Chen, Yanjie Huang, et al.
Cellular and Molecular Life Sciences (2021) Vol. 79, Iss. 1
Closed Access | Times Cited: 47
Page 1 - Next Page

Scroll to top